ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

12,817Medicare Part D Prescriptions Filled, Including Refills

Rank: 206 out of 1121

$646K Total Retail Price of All Prescriptions

Rank: 249 out of 1121

656 Patients Receiving at Least One Drug in Part D
90%Patients 65 Years and Older
26% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Tennessee
Lower avg

Schedule Two
Controlled Substances

3% of this provider’s 656 patients filled at least one prescription for a schedule two drug, compared to an average of 5%.

Schedule Three
Controlled Substances

6% of this provider’s 656 patients filled at least one prescription for a schedule three drug, compared to an average of 15%.

Risky Drugs to Seniors

2% of this provider’s 11,784 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 2%.

Brand Name Drugs

19% of this provider’s prescriptions were for brand-name drugs, compared to an average of 24%.

Prescription Price

$50 was the average price of a prescription from this provider, compared to $55 among peers.

Prescriptions per Patient

20 is the average number of prescriptions (including refills) per patient, compared to an average of 22.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Tennessee
SIMVASTATIN 694 659 1 1
AMLODIPINE BESYLATE 486 469 2 5
OMEPRAZOLE 461 429 3 6
LEVOTHYROXINE SODIUM 374 371 4 2
MELOXICAM 366 349 5 22
WARFARIN SODIUM 303 301 6 11
METOPROLOL TARTRATE 298 282 7 9
LISINOPRIL 294 248 8 4
ATENOLOL 251 223 9 16
FUROSEMIDE 241 221 10 7
QUINAPRIL HCL 234 218 11 127
METFORMIN HCL 231 205 12 8
CARVEDILOL 222 199 13 20
TRAZODONE HCL 211 206 14 40
LOSARTAN POTASSIUM 200 194 15 17
CITALOPRAM HBR 181 159 16 18
METOPROLOL SUCCINATE 180 180 17 23
TAMSULOSIN HCL 170 141 18 32
GABAPENTIN 168 149 19 13
ALENDRONATE SODIUM 167 164 20 37
RAMIPRIL 163 152 21 74
POTASSIUM CHLORIDE 158 152 22 12
SERTRALINE HCL 155 148 23 21
HYDROCHLOROTHIAZIDE 155 148 23 10
CLOPIDOGREL 144 132 25 27
GLYBURIDE 144 132 R 25 51
ATORVASTATIN CALCIUM 143 133 27 15
FLUTICASONE PROPIONATE 139 110 28 36
TRAMADOL HCL 138 135 29 25
DIOVAN 135 124 30 45
PLAVIX 126 119 31 42
ALLOPURINOL 116 111 32 30
DOXAZOSIN MESYLATE 103 103 33 93
PREDNISONE 101 94 34 43
DONEPEZIL HCL 100 100 35 35
PANTOPRAZOLE SODIUM 99 99 36 29
CALCITRIOL 83 83 37 272
FINASTERIDE 81 81 38 117
FAMOTIDINE 79 66 39 63
DIGOXIN 76 76 40 59
CRESTOR 76 74 40 28
AGGRENOX 75 75 42 177
FLUOXETINE HCL 68 56 43 60
PAROXETINE HCL 68 57 43 58
SPIRIVA 67 64 45 49
ENALAPRIL MALEATE 63 63 46 73
AZITHROMYCIN 63 58 46 44
DICLOFENAC SODIUM 63 52 46 112
GLIPIZIDE 63 59 46 84
LOSARTAN-HYDROCHLOROTHIAZIDE 60 49 50 46
VERAPAMIL ER 59 59 51 89
DILTIAZEM ER 58 58 52 105
HYDRALAZINE HCL 57 49 53 66
NEXIUM 56 44 54 24
AMITRIPTYLINE HCL 56 42 R 54 61
SYMBICORT 55 53 56 148
SPIRONOLACTONE 55 49 56 54
ISOSORBIDE MONONITRATE ER 55 55 56 62
PRAVASTATIN SODIUM 55 51 56 14
BENAZEPRIL HCL 53 53 60 41
CILOSTAZOL 51 51 61 214
PREMARIN 50 29 R 62 96
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Dec. 8, 2009.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.